Items tagged with Drug-resistant TB

In Bangladesh, an ancient disease is increasingly hard to treat (post)

Bangladesh, being densely populated, with more than 1,000 people living per square kilometre, continues to be a challenging context for control of TB. The rise of antimicrobial resistance raises the bar.

High TB prevalence seen among individuals in close contact with drug-resistant TB (post)

A high prevalence of tuberculosis (TB) was observed among individuals in close contact with patients infected with drug-resistant TB, indicating the need to improve TB screening efforts.

Researchers report potential new treatment regimens for multidrug-resistant TB meningitis (post)

Investigators used PET scans to develop what they believe will be better use of existing drugs to target TB infections in the brain and spine.

RESIST-TB August 2024 newsletter (post)

RESIST-TB released its August 2024 newsletter with the latest updates and research publications on drug-resistant TB.

Request for proposals: Fast Track the Cure: Community engagement and awareness building for new DR-TB treatments (post)

The TB Alliance Fast Track the Cure initiative launched a Request for proposals (RFP): Fast Track the Cure: Community engagement and awareness building for new drug-resistant TB (DR-TB) treatments.

Drug-resistant TB (post with image)

Stigma, isolation and a high risk of death: these are the challenges facing most drug-resistant TB patients. This article explains drug-resistance and what is fueling it.

Amikacin (post with image)

Amikacin is used as part of a treatment regimen, usually involving 5 medicines to treat MDR TB. It is part of a group of medicines called injectables.  The discovery of amikacin was published in 1976 by the Bristol-Banyu research institute in Japan.

(post with image)

(post with image)

(post with image)